VANSEN PHARMA INC. Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs
VANSEN PHARMA INC. had Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs of $5.15 million as of 2013-09-30, per its 10-Q filed 2013-12-04.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts · last filed 2013-12-04
- 2013-09-30: Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs $5.15M.
| Period end | Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Costs |
|---|---|
| 2013-09-30 | $5.15M 10-Q · filed 2013-12-04 |